Reference : Current migraine management - patient acceptability and future approaches.
Scientific journals : Article
Human health sciences : Neurology
Current migraine management - patient acceptability and future approaches.
Fumal, Arnaud mailto [Centre Hospitalier Universitaire de Liège - CHU > > Neurologie CHR >]
Schoenen, Jean mailto [Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Neuro-anatomie >]
Neuropsychiatric Disease and Treatment
Yes (verified by ORBi)
New Zealand
[en] Despite its high prevalence and individual as well as societal burden, migraine remains underdiagnosed and undertreated. In recent years, the options for the management of migraine patients have greatly expanded. A number of drugs belonging to various pharmacological classes and deliverable by several routes are now available both for the acute and the preventive treatments of migraine. Nevertheless, disability and satisfaction remain low in many subjects because treatments are not accessible, not optimized, not effective, or simply not tolerated. There is thus still considerable room for better education, for more efficient therapies and for greater support from national health systems. In spite of useful internationally accepted guidelines, anti-migraine treatment has to be individually tailored to each patient taking into account the migraine subtype, the ensuing disability, the patient's previous history and present expectations, and the co-morbid disorders. In this article we will summarize the phenotypic presentations of migraine and review recommendations for acute and preventive treatment, highlighting recent advances which are relevant for clinical practice in terms of both diagnosis and management.

File(s) associated to this reference

Fulltext file(s):

Restricted access
Current migraine management Fumal et al 08.pdfPublisher postprint312.83 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.